ODYS vs SGHT

For growth investors, Sight Sciences, Inc.

(SGHT) is the stronger pick with -3. 1% revenue growth year-over-year, versus -23. 9% for Odysight. ai Inc. (ODYS). Analysts rate Odysight. ai Inc. (ODYS) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Odysight.

ai Inc. (ODYS) delivered a total return of -61. 0%, compared to -84. 2% for Sight Sciences, Inc. (SGHT). Over 10 years, the gap is even starker: ODYS returned -38. 1% versus SGHT's -83. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Odysight.

ai Inc. (ODYS) is the lower-risk stock at -0. 11β versus Sight Sciences, Inc. 's 2. 41β — meaning SGHT is approximately -2238% more volatile than ODYS relative to the S&P 500. On balance sheet safety, Odysight. ai Inc. (ODYS) carries a lower debt/equity ratio of 3% versus 64% for Sight Sciences, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sight Sciences, Inc.

(SGHT) is pulling ahead at -3. 1% versus -23. 9% for Odysight. ai Inc. (ODYS). On earnings-per-share growth, the picture is similar: Sight Sciences, Inc. grew EPS 28. 2% year-over-year, compared to -11. 5% for Odysight. ai Inc.. Over a 3-year CAGR, ODYS leads at 65. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Odysight.

ai Inc. (ODYS) is the more profitable company, earning 36. 5% net margin versus -49. 7% for Sight Sciences, Inc. — meaning it keeps 36. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SGHT leads at -48. 0% versus -601. 5% for ODYS. At the gross margin level — before operating expenses — SGHT leads at 86. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Odysight.

ai Inc. (ODYS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 11)). Sight Sciences, Inc. (SGHT) carries a higher beta of 2. 41 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ODYS: -38. 1%, SGHT: -83. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ODYS (Technology) and SGHT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.